コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 (IC(50)) values between 24 picomolar and 35 nanomolar.
2 n A2-targeted taxane liposomes exhibited sub-nanomolar (0.69 nM) apparent equilibrium dissociation co
3 -expressing neuronal cells were treated with nanomolar Abeta(1-42) to gain insights into the molecula
4 inhibitor of activated FXII (FXIIa) with sub-nanomolar activity (K(i) = 370 +/- 40 pM) and a high sta
6 and a powerful negative chronotrope with low nanomolar activity in a neonatal rat cardiomyocyte (NRCM
7 duction, and many of these complexes exhibit nanomolar activity in vitro as well as powerful tumor in
8 Remarkably, all analogues retained the low nanomolar activity of native CIA toward muscle-type nACh
9 zoles were the most potent scaffold with mid-nanomolar activity on P. falciparum blood stage and game
11 not cause leakage and excel as carriers with nanomolar activity, with P((Cl/Na)) = 10.4 for anion/cat
12 dent TCRs (A11 and B12A) that bind with high nanomolar affinities to mouse adhesion receptor CD155.
14 lead inhibitors (iKeap1) engages KEAP1 with nanomolar affinity (dissociation constant (K(d)) = 114 n
16 he inhibitors are allosteric, they bind with nanomolar affinity and are highly specific for the 1A3 i
18 nding site to MIF, selectively bind MIF with nanomolar affinity and block MIF/CXCR4 without affecting
19 compound that specifically binds to Hb with nanomolar affinity and displays strong partitioning into
20 ive C3 and its degradation products with low nanomolar affinity and does not interfere with the endog
21 inds to 12 diverse synthetic cathinones with nanomolar affinity and does not respond to 11 structural
22 ide human cathelicidin LL-37 binds IAPP with nanomolar affinity and effectively suppresses its amyloi
24 l-DNA aptamers bind pre-miR-155 with low nanomolar affinity and high selectivity despite the inab
25 monovalent decoy, CTC-445.2, bound with low nanomolar affinity and high specificity to the receptor-
26 L-11 and IL-11Ralpha form a 1:1 complex with nanomolar affinity and present a model of the complex.
27 VHH) that bind the LRP6 P3E3P4E4 region with nanomolar affinity and strongly inhibit Wnt3/3a-induced
28 we show that cGAS binds to nucleosomes with nanomolar affinity and that nucleosome binding potently
29 with hen-egg white lysozyme demonstrate how nanomolar affinity binding of asymmetrical antigen is en
32 that this new variant exhibits single-digit nanomolar affinity for KRasGTP, confirming the computati
33 modified cell-SELEX procedure to display low-nanomolar affinity for the T-cell marker CD8) enable the
34 peptide from green mamba venom that exhibits nanomolar affinity for the V2R without any activity on 1
38 I-2852 (1), a KRAS inhibitor that binds with nanomolar affinity to a pocket, thus far perceived to be
39 the N-terminal region of Evasin-4 possessed nanomolar affinity to CCL5 and inhibited CCL5 activity i
44 AR T cells possessing micromolar rather than nanomolar affinity to ICAM-1 to avoid cytotoxicity in no
47 are highly selective for STAT3 and bind with nanomolar affinity to the N-terminal and coiled-coil dom
49 and biologically derived, with apparent mid-nanomolar affinity while discriminating against uniform
50 not inhibit coagulation, binds Tau with low nanomolar affinity, and inhibits cellular Tau aggregate
51 ctly interacted with the GPR56 ECR with high-nanomolar affinity, and used site-directed mutagenesis t
52 of CLEC14A binds one-to-one to heparin with nanomolar affinity, and using molecular modeling and mut
53 that, because native IL-37 forms dimers with nanomolar affinity, higher IL-37 only weakly suppresses
55 r findings indicate that SWG binds OSBP with nanomolar affinity, that this binding is sensitive to th
56 lded a variant with considerably higher, low-nanomolar affinity, which subsequently was shortened to
68 nositide 3-kinase gamma (PI3Kgamma), forming nanomolar-affinity, intracellular TRPV4-PI3Kgamma comple
69 and 10-100-fold increased potency (up to low nanomolar) against clinically relevant K103N, Y181C, Y18
73 conformational shifts occurring between low nanomolar and physiologically high intracellular [Ca(2+)
75 fication of cysteine-rich binding sites with nanomolar and picomolar metal affinity utilizing iodoace
76 rochromatin at a concentration as low as one nanomolar, and at this concentration there were no detec
77 affinities ranging from 100 picomolar to 10 nanomolar, and blocked SARS-CoV-2 infection of Vero E6 c
78 ically well-behaved, first-in-class hit with nanomolar anti-RABV potency that blocks RABV G protein-m
79 s (12d,e and 13c) showing similar (picomolar/nanomolar) anti-HIV-1 potency as the corresponding alpha
80 nes, leading to the discovery of potent, low nanomolar antiplasmodial compounds against a Plasmodium
81 bitors of HIV-1 integrase that exhibited low nanomolar antiviral potency in cell culture and encourag
83 with coactivator yes-associated protein with nanomolar apparent IC(50) values, and reduce TEAD target
84 cells demonstrate that NDD-713 and -825 have nanomolar beta1-AR affinity >500-fold beta1-AR vs beta2-
85 ntification of key interactions critical for nanomolar binding affinity and high selectivity of A9g f
86 he obtained compounds described here exhibit nanomolar binding affinity and mechanism-based cellular
92 96 disturbed the microtubule dynamics at the nanomolar concentration in A375 and B16F10 melanoma cell
94 CH-3-8 disrupted microtubule dynamics at the nanomolar concentration in MIA PaCa-2 and PANC-1 pancrea
95 diastereomers was possible down to the lower nanomolar concentration range, and enantiomeric ratios c
98 One of the developed dyes could be used at a nanomolar concentration to selectively stain lipid dropl
100 ds and proteins bearing aromatic residues at nanomolar concentration, i.e., a full order of magnitude
103 The dyes inhibited parasite proliferation at nanomolar concentrations (0.019-1.83 muM) and a synergis
104 showed potent antiplasmodial activity at low nanomolar concentrations (EC50 <500 nM) and low cytotoxi
105 ]JW199, labels active NCEH1 in live cells at nanomolar concentrations and greater than 1000-fold sele
106 preferential cytotoxicity towards PEL at low nanomolar concentrations and is approximately 10 and 100
107 ctively inhibits leukemia cell growth at low nanomolar concentrations and is capable of achieving par
108 oxic compounds known to kill cancer cells at nanomolar concentrations by targeting the microtubule ne
109 imetric detection of synthetic cathinones at nanomolar concentrations in biological samples is achiev
110 SD-36 induces rapid STAT3 degradation at low nanomolar concentrations in cells and fails to degrade o
112 rolimus in the treatment of HGG cells at low nanomolar concentrations of both agents, with a reductio
113 milar to many other FPR2 agonistic peptides, nanomolar concentrations of both PSMalpha2 and PSMalpha3
114 range (1.6 nM to 1 muM) and was sensitive to nanomolar concentrations of glucose with a very low limi
115 E2) biomaterial scaffolds that release E2 at nanomolar concentrations over the course of 1-10 years v
117 endent manner, from cell-cycle arrest at low nanomolar concentrations to cell death at concentrations
120 eficial effects in globin gene expression at nanomolar concentrations without perturbing erythroid ex
122 ed as selective live cell imaging probes (at nanomolar concentrations) and stained lipid-based struct
123 This was achieved at biologically relevant, nanomolar concentrations, allowing determination of pona
124 tro, paclitaxel was found to be effective at nanomolar concentrations, complement therapy with temozo
125 at is endowed with an inhibitory activity at nanomolar concentrations, suitable pharmacokinetic prope
126 nt ligation of peptide fragments down to low nanomolar concentrations, without resorting to solubilit
138 s, we discovered potent HDAC6 degraders with nanomolar DC(50) and promising antiproliferation activit
139 HTP(2) MOFs for the detection of 5-HT with a nanomolar detection limit of 63 +/- 11 nM for 5-HT throu
140 n particular, Ni(3)HHTP(2) MOFs demonstrated nanomolar detection limits of 63 +/- 11 nM for DA and 40
142 We produced more than 20 synbodies with low nanomolar dissociation constants (KD < 10 nM) for GII.4
143 nserved P-H...pai interaction, which confers nanomolar dissociation constants for their respective li
146 hat, upon treatment with clinically-relevant nanomolar doses of the Topoisomerase I inhibitor camptot
147 VoltageSpy enables voltage imaging with low nanomolar dye concentration and offers a promising metho
148 killed cultured P. falciparum parasites with nanomolar efficacy and did not give rise to new resistan
152 om 5 fM to 73 nM), which translated into sub-nanomolar gammadelta T-cell-mediated eradication of blad
153 llent antiproliferative properties, with low nanomolar GI50 values (16o, mean GI50 of 3.3 nM) against
154 ), yielding short-, medium-, and long-acting nanomolar hBChE inhibitors (with a half-life of the carb
157 and to the development of BAY-298, the first nanomolar hLH-R antagonist reducing sex hormone levels i
159 ition of growth of RS4;11 cells and also low nanomolar IC(50) values in a panel of leukemia cell line
160 a panel of primary AML blast cells, with low nanomolar IC(50)s and, based on colony-forming unit assa
161 rt a SPIN1 chemical probe inhibitor with low nanomolar in vitro activity, exquisite selectivity on a
162 ofuran-3(2H)-one scaffold that possessed low nanomolar in vitro potency in cell proliferation assays
166 revealed several combinations that produced nanomolar inhibition, and seven unique pairs produced gr
168 resent a thorough description of the potent, nanomolar inhibitor [2-(2-methoxy-5H-1,4b,9-triaza(inden
173 l fragment screening hit led to double-digit nanomolar inhibitors of SPR with excellent ligand effici
174 n inhibitor of HDACs, AES-135, that exhibits nanomolar inhibitory activity against HDAC3, HDAC6, and
175 The compounds reach low micromolar to upper nanomolar inhibitory potency in cell-based assays, are s
176 lected aptamers bind with high affinity (low nanomolar K(d) values) and selectivity to exposed surfac
177 bind alternative G4DNA topologies with a low nanomolar Kd value of approximately 2 nm, similar to tha
179 h IDO1, to the inhibitory potency at the low nanomolar level in several tumoral settings, and to the
180 continuously monitoring fentanyl down to the nanomolar level through a nanomaterial-based multilayere
181 ent activity with GI(50) values reaching the nanomolar level, with mean graph midpoints of 0.08-0.41
184 Melor is successfully evaluated by detecting nanomolar levels of various small molecules, including u
185 IspH inhibitors and refine their potency to nanomolar levels through structure-guided analogue desig
190 rm" to codetect guanosine and adenosine with nanomolar limits of detection in real time with FSCV.
191 DE1 isoforms, with IC(50) values in the high nanomolar/low micromolar concentration range, and showed
192 This enabled the discovery of the first low nanomolar LRH-1 agonist, one hundred times more potent t
193 h the limit of detection (LOD) down to a few nanomolar (<3 nM), which is close to the World Health Or
194 eous detection of picomolar (pM) insulin and nanomolar (nM) cortisol concentrations in a single micro
195 respective chemokines with affinities in the nanomolar (nM) range, similar to the affinities of nativ
196 human polySia-specific mAb that retained low nanomolar (nmol/L) target affinity and exhibited exquisi
197 The key compound VUF16839 (14d) combines nanomolar on-target activity (pK(i) = 8.5, pEC(50) = 9.5
198 res of three macrocyclic inhibitors with low nanomolar or subnanomolar potency in complex with CatD a
200 zymes provides a detection platform with low nanomolar peptide substrate consumption, and the assay i
201 simultaneously inhibited PI3K and HDAC with nanomolar potencies and demonstrated favorable antiproli
202 ation of a series of VHL inhibitors with low nanomolar potencies and improved cellular permeability.
203 esistant EGFR(L858R/T790M/C797S) mutant with nanomolar potencies in a reversible binding mechanism.
204 ionship of these two scaffolds, resulting in nanomolar potencies in an ATP synthesis inhibition assay
205 ioxidant capsaicin results in compounds with nanomolar potencies toward human acetylcholinesterase (A
208 lines identified eight analogues displaying nanomolar potency (IC(50) ranging from 1 to 32 nM), high
210 with nanomolar potency against CA IX and sub-nanomolar potency against CA II and CA IV, and with pote
212 ly-selective inhibitor, CCG258747, which has nanomolar potency against GRK2 and excellent selectivity
215 collection of natural products that display nanomolar potency against select isoforms of eukaryotic
216 tic marine natural product with reported sub-nanomolar potency against several cancer cell lines.
217 les (AB) protein kinase inhibitors that show nanomolar potency against T. brucei bloodstream forms, L
218 eries of thienopyrimidinone derivatives with nanomolar potency against TrmD in vitro and discovered a
222 igand efficiency (LLE = 8.5), which displays nanomolar potency in cells (peripheral blood mononuclear
229 mproved oral glucose tolerance produced by a nanomolar-potency inhibitor of calcium-activated chlorid
231 This led to the identification of LEI-301, a nanomolar potent inhibitor for the PLAAT family members.
233 activity by 10-fold, affording LEI-401 as a nanomolar potent inhibitor with drug-like properties.
239 wth of Plasmodium falciparum in vitro in the nanomolar range (IC(50) = 74 nM) with high selectivity i
240 rs for cocaine/quinine (MN4), chosen for its nanomolar range affinity, and l-argininamide (1OLD) to s
241 ometallics showed inhibitory activity in the nanomolar range against histone deacetylases (HDACs) as
242 he analogues displayed IC(50) within the low nanomolar range against Trypanosoma cruzi, with very hig
243 hese, three compounds showed activity in the nanomolar range and one, 2-((4-fluoro-3-(trifluoromethyl
244 phototoxicity in the very low micromolar to nanomolar range at clinically relevant 595 nm, in monola
245 ree aptamers with a reported affinity in the nanomolar range for ampicillin, a beta-lactam antibiotic
246 PR) with dissociation constants (Kd ) in the nanomolar range for choline and glycine betaine, micromo
247 23d, 23e, 23f, and 23h) were identified with nanomolar range potency based on a systematic structure-
249 their low circulating concentrations (in the nanomolar range) and poor fragmentation characteristics
250 rapid and highly sensitive target detection (nanomolar range) in complex media such as human serum.
251 indicator Cal-590 is Ca(2+)-sensitive in the nanomolar range, and employ it in combination with green
252 CAs IX and XII, with K(I) values in the low nanomolar range, and strong antitelomerase activity in P
253 ibitory concentration (IC(50)) values in the nanomolar range, and the broadest bNAbs neutralize up to
254 results, showing limits of detection in the nanomolar range, confirm the validity of the proposed ap
255 arPEG-(KA7)(4) binds microtubules in the low nanomolar range, diffuses along their lattice with the a
256 affinities toward alpha(V)beta(3) in the low nanomolar range, good selectivity, and high plasma stabi
258 ains with affinities in the picomolar to low nanomolar range, orders of magnitude higher than unoptim
259 c anhydrase (hCA) IX and XII isoforms in the nanomolar range, while no affinity was encountered for o
277 the catalytic activity of USP2 in vitro with nanomolar-range potencies, and they bound and inhibited
278 n deep tissue, providing a basis for mapping nanomolar-scale analytes without the radiation or heavy
279 he mobile translocation is the major form at nanomolar ScPif1 concentrations although patrolling beco
280 toring of analytes in vivo have only reached nanomolar sensitivity and can measure only a handful of
281 ffects of PZQ on schistosomes, including (i) nanomolar sensitivity to PZQ; (ii) stereoselectivity tow
282 ives of the antibiotic tetracycline exhibits nanomolar sensitivity with visual detection of bead fluo
285 we report the development of a series of low nanomolar, small-molecule inhibitors of human ACLY.
286 ized by micromolar solubilities give rise to nanomolar soluble concentrations in healthy animal arter
288 combined submicromolar cellular potency and nanomolar target affinity with balanced physicochemical
290 ng, binding affinities to the chromophore in nanomolar to low micromolar range, and high photostabili
292 ge over three orders of magnitude in the low nanomolar to micromolar concentration range and limit of
293 with very different binding affinities (low nanomolar to millimolar) for an integral membrane transp
294 ntative examples of the series also showed a nanomolar to picomolar efficacy against patient-derived
295 ificantly improved anti-HAdV activities with nanomolar to submicromolar IC(50) values and high select
296 aF/F(0) response to NE, good photostability, nanomolar-to-micromolar sensitivities, sub-second kineti
298 ivity score metric capable of discriminating nanomolar versus micromolar sensitivity to a cell-permea
299 s aqueous solubility is ~200 fold lower (~60 nanomolar), whereas the potency of its stimulatory effec
300 ighly sensitive probes for investigating sub-nanomolar Zn(2+) dynamics, but also reveals new pools of